N1 and N2 Neutrophil Polarization in Breast Cancer: Predictive Value for Treatment Outcomes

Emmanuel Ifeanyi  Obeagu; Isaac  Isiko

doi:10.22270/ijmspr.v11i2.142

Authors

Emmanuel Ifeanyi Obeagu Department of Biomedical and Laboratory Science, Africa University, Zimbabwe https://orcid.org/0000-0002-4538-0161
Isaac Isiko Department of Community Medicine, Axel Pries Institute of Public Health and Biomedical Sciences, Nims University, Jaipur, Rajasthan State, India https://orcid.org/0000-0002-3612-5054

DOI:

https://doi.org/10.22270/ijmspr.v11i2.142

Keywords:

N1 neutrophils, N2 neutrophils, neutrophil polarization, breast cancer, treatment outcomes

Abstract

Neutrophils, the most abundant white blood cells in the immune system, play a crucial role in breast cancer progression through their ability to polarize into two distinct phenotypes: N1 and N2. N1 neutrophils are considered antitumor effector cells that promote immune responses and inhibit tumour growth, while N2 neutrophils support tumour progression by promoting inflammation, immune suppression, and metastasis. The balance between these two phenotypes within the tumour microenvironment (TME) can significantly influence breast cancer development and response to treatment. The polarization of neutrophils in the TME is influenced by various factors, including cytokines, growth factors, and interactions with other immune cells. N1 neutrophils exhibit pro-inflammatory and cytotoxic properties that help limit tumour growth, while N2 neutrophils contribute to an immunosuppressive microenvironment that facilitates cancer progression and therapy resistance. Studies suggest that an increased presence of N1 neutrophils correlates with improved prognosis and response to therapies, whereas a predominance of N2 neutrophils is often associated with poor treatment outcomes and increased metastatic potential. This review examines the mechanisms underlying neutrophil polarization and the implications of these phenotypes on treatment responses in breast cancer.

Keywords: N1 neutrophils, N2 neutrophils, neutrophil polarization, breast cancer, treatment outcomes

Author Biographies

Emmanuel Ifeanyi Obeagu , Department of Biomedical and Laboratory Science, Africa University, Zimbabwe

Department of Biomedical and Laboratory Science, Africa University, Zimbabwe

Isaac Isiko , Department of Community Medicine, Axel Pries Institute of Public Health and Biomedical Sciences, Nims University, Jaipur, Rajasthan State, India

Department of Community Medicine, Axel Pries Institute of Public Health and Biomedical Sciences, Nims University, Jaipur, Rajasthan State, India

References

Elyasinia F, Keramati MR, Ahmadi F, Rezaei S, Ashouri M, Parsaei R, Yaghoubi M, Elyasinia F, Aboutorabi A, Kaviani A. Neutrophil-lymphocyte ratio in different stages of breast cancer. Acta MedicaIranica. 2017 :228-32.

Wu L, Saxena S, Awaji M, Singh RK. Tumor-associated neutrophils in cancer: going pro. Cancers. 2019 ;11(4):564. https://doi.org/10.3390/cancers11040564 PMid:31010242 PMCid:PMC6520693

Jaillon S, Ponzetta A, Di Mitri D, Santoni A, Bonecchi R, Mantovani A. Neutrophil diversity and plasticity in tumour progression and therapy. Nature Reviews Cancer. 2020 ;20(9):485-503. https://doi.org/10.1038/s41568-020-0281-y PMid:32694624

Schernberg A, Mezquita L, Boros A, Botticella A, Caramella C, Besse B, Escande A, Planchard D, Le Péchoux C, Deutsch E. Neutrophilia as prognostic biomarker in locally advanced stage III lung cancer. PloS one. 2018 ;13(10):e0204490. https://doi.org/10.1371/journal.pone.0204490 PMid:30304046 PMCid:PMC6179235

Chung JY, Tang PC, Chan MK, Xue VW, Huang XR, Ng CS, Zhang D, Leung KT, Wong CK, Lee TL, Lam EW. Smad3 is essential for polarization of tumor-associated neutrophils in non-small cell lung carcinoma. Nature Communications. 2023 Mar 31;14(1):1794. https://doi.org/10.1038/s41467-023-37515-8 PMid:37002229 PMCid:PMC10066366

Shaul ME, Fridlender ZG. Neutrophils as active regulators of the immune system in the tumor microenvironment. Journal of leukocyte biology. 2017 Aug;102(2):343-9. https://doi.org/10.1189/jlb.5MR1216-508R PMid:28264904

Wang J, Ocadiz-Ruiz R, Hall MS, Bushnell GG, Orbach SM, Decker JT, Raghani RM, Zhang Y, Morris AH, Jeruss JS, Shea LD. A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs. Nature communications. 2023 Aug 8;14(1):4790. https://doi.org/10.1038/s41467-023-40478-5 PMid:37553342 PMCid:PMC10409732

Tabariès S, Ouellet V, Hsu BE, Annis MG, Rose AA, Meunier L, Carmona E, Tam CE, Mes-Masson AM, Siegel PM. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Breast cancer research. 2015 Dec;17:1-8. https://doi.org/10.1186/s13058-015-0558-3 PMid:25882816 PMCid:PMC4413545

Henkels KM, Muppani NR, Gomez-Cambronero J. PLD-specific small-molecule inhibitors decrease tumor-associated macrophages and neutrophils infiltration in breast tumors and lung and liver metastases. PLoS One. 2016 Nov 16;11(11):e0166553. https://doi.org/10.1371/journal.pone.0166553 PMid:27851813 PMCid:PMC5112812

Wu G, Pan B, Shi H, Yi Y, Zheng X, Ma H, Zhao M, Zhang Z, Cheng L, Huang Y, Guo W. Neutrophils' dual role in cancer: from tumor progression to immunotherapeutic potential. International Immunopharmacology. 2024 Oct 25;140:112788. https://doi.org/10.1016/j.intimp.2024.112788 PMid:39083923

Mahmud Z, Rahman A, Mishu ID, Kabir Y. Mechanistic insights into the interplays between neutrophils and other immune cells in cancer development and progression. Cancer and Metastasis Reviews. 2022 Jun;41(2):405-432. https://doi.org/10.1007/s10555-022-10024-8 PMid:35314951

Tyagi A, Wu SY, Sharma S, Wu K, Zhao D, Deshpande R, Singh R, Li W, Topaloglu U, Ruiz J, Watabe K. Exosomal miR-4466 from nicotine-activated neutrophils promotes tumor cell stemness and metabolism in lung cancer metastasis. Oncogene. 2022 May 27;41(22):3079-3092. https://doi.org/10.1038/s41388-022-02322-w PMid:35461327 PMCid:PMC9135627

Bonavita O, Massara M, Bonecchi R. Chemokine regulation of neutrophil function in tumors. Cytokine & growth factor reviews. 2016 Aug 1;30:81-86. https://doi.org/10.1016/j.cytogfr.2016.03.012 PMid:27021826

Zhong J, Zong S, Wang J, Feng M, Wang J, Zhang H, Xiong L. Role of neutrophils on cancer cells and other immune cells in the tumor microenvironment. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research. 2023 Oct 1;1870(7):119493. https://doi.org/10.1016/j.bbamcr.2023.119493 PMid:37201766

Powell DR, Huttenlocher A. Neutrophils in the tumor microenvironment. Trends in immunology. 2016 Jan 1;37(1):41-52. https://doi.org/10.1016/j.it.2015.11.008 PMid:26700397 PMCid:PMC4707100

Vazquez Rodriguez G, Abrahamsson A, Jensen LD, Dabrosin C. Estradiol promotes breast cancer cell migration via recruitment and activation of neutrophils. Cancer immunology research. 2017 Mar 1;5(3):234-247. https://doi.org/10.1158/2326-6066.CIR-16-0150 PMid:28159748

Galdiero MR, Garlanda C, Jaillon S, Marone G, Mantovani A. Tumor associated macrophages and neutrophils in tumor progression. Journal of cellular physiology. 2013 Jul;228(7):1404-1412. https://doi.org/10.1002/jcp.24260 PMid:23065796

Zhang Y, Guoqiang L, Sun M, Lu X. Targeting and exploitation of tumor-associated neutrophils to enhance immunotherapy and drug delivery for cancer treatment. Cancer biology & medicine. 2020 Feb 2;17(1):32. https://doi.org/10.20892/j.issn.2095-3941.2019.0372 PMid:32296575 PMCid:PMC7142839

Wang P, Xu MH, Xu WX, Dong ZY, Shen YH, Qin WZ. CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils. Journal of Hepatocellular Carcinoma. 2024 Dec 31:787-800. https://doi.org/10.2147/JHC.S450468 PMid:38737384 PMCid:PMC11088828

Huang X, Nepovimova E, Adam V, Sivak L, Heger Z, Valko M, Wu Q, Kuca K. Neutrophils in Cancer immunotherapy: friends or foes?. Molecular Cancer. 2024 May 18;23(1):107. https://doi.org/10.1186/s12943-024-02004-z PMid:38760815 PMCid:PMC11102125

Timaxian C, Vogel CF, Orcel C, Vetter D, Durochat C, Chinal C, NGuyen P, Aknin ML, Mercier-Nomé F, Davy M, Raymond-Letron I. Pivotal role for Cxcr2 in regulating tumor-associated neutrophil in breast cancer. Cancers. 2021 May 25;13(11):2584. https://doi.org/10.3390/cancers13112584 PMid:34070438 PMCid:PMC8197482

Siwicki M, Pittet MJ. Versatile neutrophil functions in cancer. InSeminars in Immunology 2021;57:101538). Academic Press. https://doi.org/10.1016/j.smim.2021.101538 PMid:34876331

Peng H, Shen J, Long X, Zhou X, Zhang J, Xu X, Huang T, Xu H, Sun S, Li C, Lei P. Local release of TGF‐β inhibitor modulates tumor‐associated neutrophils and enhances pancreatic cancer response to combined irreversible electroporation and immunotherapy. Advanced Science. 2022 Apr;9(10):2105240. https://doi.org/10.1002/advs.202105240 PMid:35128843 PMCid:PMC8981446

Arvanitakis K, Mitroulis I, Germanidis G. Tumor-associated neutrophils in hepatocellular carcinoma pathogenesis, prognosis, and therapy. Cancers. 2021 Jun 10;13(12):2899. https://doi.org/10.3390/cancers13122899 PMid:34200529 PMCid:PMC8228651

Mizuno R, Kawada K, Itatani Y, Ogawa R, Kiyasu Y, Sakai Y. The role of tumor-associated neutrophils in colorectal cancer. International journal of molecular sciences. 2019 Jan 27;20(3):529. https://doi.org/10.3390/ijms20030529 PMid:30691207 PMCid:PMC6386937

Xu W, Weng J, Xu M, Zhou Q, Liu S, Hu Z, Ren N, Zhou C, Shen Y. Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization. Cancer Immunology, Immunotherapy. 2024 Feb 17;73(3):56. https://doi.org/10.1007/s00262-024-03650-4 PMid:38367070 PMCid:PMC10874310

Barreno L, Sevane N, Valdivia G, Alonso-Miguel D, Suarez-Redondo M, Alonso-Diez A, Fiering S, Beiss V, Steinmetz NF, Perez-Alenza MD, Peña L. Transcriptomics of canine inflammatory mammary cancer treated with empty cowpea mosaic virus implicates neutrophils in anti-tumor immunity. International Journal of Molecular Sciences. 2023 Sep 13;24(18):14034. https://doi.org/10.3390/ijms241814034 PMid:37762335 PMCid:PMC10531449

Cuartero MI, Ballesteros I, Moraga A, Nombela F, Vivancos J, Hamilton JA, Corbí ÁL, Lizasoain I, Moro MA. N2 neutrophils, novel players in brain inflammation after stroke: modulation by the PPARγ agonist rosiglitazone. Stroke. 2013 Dec;44(12):3498-3508. https://doi.org/10.1161/STROKEAHA.113.002470 PMid:24135932

Pan YC, Nishikawa T, Chang CY, Tai JA, Kaneda Y. CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy. Molecular Therapy-Oncolytics. 2021 Mar 26;20:175-186. https://doi.org/10.1016/j.omto.2020.12.011 PMid:33575480 PMCid:PMC7851488

Zou JM, Qin J, Li YC, Wang Y, Li D, Shu Y, Luo C, Wang SS, Chi G, Guo F, Zhang GM. IL-35 induces N2 phenotype of neutrophils to promote tumor growth. Oncotarget. 2017 May 5;8(20):33501. https://doi.org/10.18632/oncotarget.16819 PMid:28432279 PMCid:PMC5464885

Reichardt CM, Muñoz-Becerra M, RiusRigau A, Rückert M, Fietkau R, Schett G, Gaipl US, Frey B, Muñoz LE. Neutrophils seeking new neighbors: radiotherapy affects the cellular framework and the spatial organization in a murine breast cancer model. Cancer Immunology, Immunotherapy. 2024 Mar 2;73(4):67. https://doi.org/10.1007/s00262-024-03653-1 PMid:38430241 PMCid:PMC10908631

Yang J, Xie Y, Xia Z, Ji S, Yang X, Yue D, Liu Y, Yang R, Fan Y. HucMSC-Exo Induced N2 Polarization of Neutrophils: Implications for Angiogenesis and Tissue Restoration in Wound Healing. International Journal of Nanomedicine. 2024 Dec 31:3555-3575. https://doi.org/10.2147/IJN.S458295 PMid:38638364 PMCid:PMC11024985

Wu Q, Mao H, Jiang Z, Tang D. Tumour‐associated neutrophils: Potential therapeutic targets in pancreatic cancer immunotherapy. Immunology. 2024 Jul;172(3):343-361. https://doi.org/10.1111/imm.13765 PMid:38402904

Zhang L, Pan J, Wang M, Yang J, Zhu S, Li L, Hu X, Wang Z, Pang L, Li P, Jia F. Chronic Stress‐Induced and Tumor Derived SP1+ Exosomes Polarizing IL‐1β+ Neutrophils to Increase Lung Metastasis of Breast Cancer. Advanced Science. 2024:2310266. https://doi.org/10.1002/advs.202310266 PMid:39630109 PMCid:PMC11789585

Hajizadeh F, Maleki LA, Alexander M, Mikhailova MV, Masjedi A, Ahmadpour M, Hashemi V, Jadidi-Niaragh F. Tumor-associated neutrophils as new players in immunosuppressive process of the tumor microenvironment in breast cancer. Life sciences. 2021 ;264:118699. https://doi.org/10.1016/j.lfs.2020.118699 PMid:33137368

Al Qutami F, Al Halabi W, Hachim MY. Identification of breast cancer LCK proto-oncogene as a master regulator of TNBC neutrophil enrichment and polarization. International journal of molecular sciences. 2023 ;24(17):13269. https://doi.org/10.3390/ijms241713269 PMid:37686072 PMCid:PMC10487917

Zheng C, Xu X, Wu M, Xue L, Zhu J, Xia H, Ding S, Fu S, Wang X, Wang Y, He G. Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance. Breast Cancer Research. 2023 ;25(1):88. https://doi.org/10.1186/s13058-023-01676-7 PMid:37496019 PMCid:PMC10373263

Shaul ME, Fridlender ZG. Tumour-associated neutrophils in patients with cancer. Nature reviews Clinical oncology. 2019 ;16(10):601-620. https://doi.org/10.1038/s41571-019-0222-4 PMid:31160735

Schernberg A, Blanchard P, Chargari C, Deutsch E. Neutrophils, a candidate biomarker and target for radiation therapy?. Acta oncologica. 2017 ;56(11):1522-1530. https://doi.org/10.1080/0284186X.2017.1348623 PMid:28835188

Li Z, Zhao R, Cui Y, Zhou Y, Wu X. The dynamic change of neutrophil to lymphocyte ratio can predict clinical outcome in stage I-III colon cancer. Scientific reports. 2018 ;8(1):9453. https://doi.org/10.1038/s41598-018-27896-y PMid:29930287 PMCid:PMC6013456

Wang P, Xu MH, Xu WX, Dong ZY, Shen YH, Qin WZ. CXCL9 Overexpression Predicts Better HCC Response to Anti-PD-1 Therapy and Promotes N1 Polarization of Neutrophils. Journal of Hepatocellular Carcinoma. 2024 :787-800. https://doi.org/10.2147/JHC.S450468 PMid:38737384 PMCid:PMC11088828

Masucci MT, Minopoli M, Carriero MV. Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy. Frontiers in oncology. 2019 ;9:1146. https://doi.org/10.3389/fonc.2019.01146 PMid:31799175 PMCid:PMC6874146

Senovilla L, Vacchelli E, Galon J, Adjemian S, Eggermont A, Fridman WH, Sautès-Fridman C, Ma Y, Tartour E, Zitvogel L, Kroemer G. Trial watch: Prognostic and predictive value of the immune infiltrate in cancer. Oncoimmunology. 2012 ;1(8):1323-1343. https://doi.org/10.4161/onci.22009 PMid:23243596 PMCid:PMC3518505

Bruni D, Angell HK, Galon J. The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nature Reviews Cancer. 2020 ;20(11):662-680. https://doi.org/10.1038/s41568-020-0285-7 PMid:32753728

Xu W, Weng J, Xu M, Zhou Q, Liu S, Hu Z, Ren N, Zhou C, Shen Y. Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarization. Cancer Immunology, Immunotherapy. 2024 ;73(3):56. https://doi.org/10.1007/s00262-024-03650-4 PMid:38367070 PMCid:PMC10874310

Huang YC, Chang CY, Wu YY, Wu KL, Tsai YM, Lee HC, Tsai EM, Hsu YL. Single-cell transcriptomic profiles of lung pre-metastatic niche reveal neutrophil and lymphatic endothelial cell roles in breast cancer. Cancers. 2022 ;15(1):176. https://doi.org/10.3390/cancers15010176 PMid:36612175 PMCid:PMC9818165

Wu Y, Liu H, Sun Z, Liu J, Li K, Fan R, Dai F, Tang H, Hou Q, Li J, Tang X. The adhesion-GPCR ADGRF5 fuels breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects. Cell Death & Disease. 2024 ;15(6):455. https://doi.org/10.1038/s41419-024-06855-8 PMid:38937435 PMCid:PMC11211477

Gianni C, Palleschi M, Schepisi G, Casadei C, Bleve S, Merloni F, Sirico M, Sarti S, Cecconetto L, Di Menna G, Schettini F. Circulating inflammatory cells in patients with metastatic breast cancer: Implications for treatment. Frontiers in oncology. 2022 ;12:882896. https://doi.org/10.3389/fonc.2022.882896 PMid:36003772 PMCid:PMC9393759

Jadoon, S.K., Soomro, R., Ahsan, M.N., Khan, R.M.I., Iqbal, S., Yasmin, F., Najeeb, H., Saleem, N., Cho, N., Shaikh, T.G. and Hasan, S.F.S., 2023. Association of neutrophil-to-lymphocyte ratio with clinical, pathological, radiological, laboratory features and disease outcomes of invasive breast cancer patients: A retrospective observational cohort study. Medicine, 102(20), p.e33811. https://doi.org/10.1097/MD.0000000000033811 PMid:37335707 PMCid:PMC10194494

Tabariès S, Ouellet V, Hsu BE, Annis MG, Rose AA, Meunier L, Carmona E, Tam CE, Mes-Masson AM, Siegel PM. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases. Breast cancer research. 2015 ;17:1-8. https://doi.org/10.1186/s13058-015-0558-3 PMid:25882816 PMCid:PMC4413545

Hu P, Liu Q, Deng G, Zhang J, Liang N, Xie J, Zhang J. Radiosensitivity nomogram based on circulating neutrophils in thoracic cancer. Future Oncology. 2019 ;15(7):727-737. https://doi.org/10.2217/fon-2018-0398 PMid:30693787

Wang J, Ocadiz-Ruiz R, Hall MS, Bushnell GG, Orbach SM, Decker JT, Raghani RM, Zhang Y, Morris AH, Jeruss JS, Shea LD. A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs. Nature communications. 2023 ;14(1):4790. https://doi.org/10.1038/s41467-023-40478-5 PMid:37553342 PMCid:PMC10409732

Schmidt E, Distel L, Erber R, Büttner-Herold M, Rosahl MC, Ott OJ, Strnad V, Hack CC, Hartmann A, Hecht M, Fietkau R. Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment. Cancers. 2024 ;16(18):3160. https://doi.org/10.3390/cancers16183160 PMid:39335132 PMCid:PMC11430230

Grassadonia A, Graziano V, Iezzi L, Vici P, Barba M, Pizzuti L, Cicero G, Krasniqi E, Mazzotta M, Marinelli D. Prognostic relevance of neutrophil to lymphocyte ratio (NLR) in luminal breast cancer: a retrospective analysis in the neoadjuvant setting. Cells. 2021;10(7):1685. https://doi.org/10.3390/cells10071685 PMid:34359855 PMCid:PMC8303552

Liu S, Wu W, Du Y, Yin H, Chen Q, Yu W, Wang W, Yu J, Liu L, Lou W, Pu N. The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications. Molecular Cancer. 2023 ;22(1):148. https://doi.org/10.1186/s12943-023-01843-6 PMid:37679744 PMCid:PMC10483725

Azab BN, Bhatt VR, Vonfrolio S, Bachir R, Rubinshteyn V, Alkaied H, Habeshy A, Patel J, Picon AI, Bloom SW. Value of the pretreatment albumin to globulin ratio in predicting long-term mortality in breast cancer patients. The American Journal of Surgery. 2013 ;206(5):764-770. https://doi.org/10.1016/j.amjsurg.2013.03.007 PMid:23866764

Zhang J, Yu D, Ji C, Wang M, Fu M, Qian Y, Zhang X, Ji R, Li C, Gu J, Zhang X. Exosomal miR-4745-5p/3911 from N2-polarized tumor-associated neutrophils promotes gastric cancer metastasis by regulating SLIT2. Molecular Cancer. 2024 ;23(1):198. https://doi.org/10.1186/s12943-024-02116-6 PMid:39272149 PMCid:PMC11396805